ClinicalTrials.govpublic full text
Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjects
non-alcoholic fatty liver disease, ljn452, tropifexor, pk, safety, healthy subjects, hepatically impaired, nonalcoholic steatohepatitis, nonalcoholic fatty liver disease, nafld, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 857672
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.